ArticleFrontiers in surgery2025
The efficacy of early progressive resistance exercise in the postoperative management of pancreaticoduodenectomy for pancreatic cancer: a randomized controlled trial.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Best evidence summary of exercise rehabilitation in patients undergoing pancreaticoduodenectomy.Asia-Pacific journal of oncology nursing · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enhanced Recovery After Surgery (ERAS) is of significant importance to the prognosis of patients with pancreatic cancer who have undergone pancreaticoduodenectomy. This study aims to analyze the efficacy of early progressive resistance exercise in the postoperative management of pancreaticoduodenectomy for pancreatic cancer, thereby providing evidence-based support for clinical treatment and nursing. Methods: This study enrolled patients who underwent pancreaticoduodenectomy for pancreatic cancer at our hospital from January 2023 to December 2024. Participants were randomized into two groups using a random number table: the progressive resistance exercise group and the control group. The control group received standard care, while the progressive resistance exercise group underwent the progressive resistance exercise protocol in addition to standard care. Results: A total of 80 patients who underwent pancreaticoduodenectomy for pancreatic cancer were included in the study, with 40 patients assigned to each group. Progressive resistance exercise significantly reduced the time to first water intake, time to first food intake, time to first ambulation, and duration of hospital stay (all Conclusion: Progressive resistance exercise has been demonstrated to effectively promote functional recovery and overall rehabilitation in patients with pancreatic cancer following pancreaticoduodenectomy. Given its significant benefits, the integration of progressive resistance exercise into clinical practice and nursing protocols is recommended.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.